PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+28.48%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$4.35B
AUM Growth
+$4.35B
(+7.6%)
Cap. Flow
-$515M
Cap. Flow
% of AUM
-11.84%
Top 10 Holdings %
Top 10 Hldgs %
52.87%
Holding
159
New
12
Increased
33
Reduced
61
Closed
13
Top Buys
| 1 |
Louisiana-Pacific
LPX
|
$66.3M |
| 2 |
LyondellBasell Industries
LYB
|
$64.7M |
| 3 |
Ulta Beauty
ULTA
|
$39.8M |
| 4 |
Wabtec
WAB
|
$36.9M |
| 5 |
X
US Steel
X
|
$23.9M |
Top Sells
| 1 |
Booking.com
BKNG
|
$91.4M |
| 2 |
Alibaba
BABA
|
$84.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$58.6M |
| 4 |
Vail Resorts
MTN
|
$53.5M |
| 5 |
GOGL
Golden Ocean Group
GOGL
|
$45.8M |
Sector Composition
| 1 | Consumer Discretionary | 25.71% |
| 2 | Industrials | 21.51% |
| 3 | Technology | 19.57% |
| 4 | Materials | 8.65% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Starbucks
SBUX
$100B
| $7.24M | 0.17% | +67,648 | New | +$7.24M |
|
52
United Parks & Resorts
PRKS
$2.89B
| $7.16M | 0.16% | 226,546 -71,027 | -24% | -$2.24M |
|
53
Wyndham Hotels & Resorts
WH
$6.61B
| $6.32M | 0.15% | 106,399 | – | – |
|
|
MYOV
54
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.19M | 0.14% | 224,083 -27,556 | -11% | -$761K |
|
|
GTH
55
DELISTED
Genetron Holdings Limited ADS
GTH
| $5.89M | 0.14% | 420,444 +45,085 | +12% | +$631K |
|
56
Microsoft
MSFT
$3.77T
| $5.56M | 0.13% | 24,998 | – | – |
|
57
Cogent Biosciences
COGT
$1.69B
| $5.34M | 0.12% | +475,705 | New | +$5.34M |
|
58
Assembly Biosciences
ASMB
$190M
| $4.97M | 0.11% | 821,886 +596,994 | +265% | +$3.61M |
|
|
59
Vail Resorts
MTN
$6.09B
| $4.77M | 0.11% | 17,094 -191,870 | -92% | -$53.5M |
|
|
CNTG
60
DELISTED
Centogene N.V. Common Shares
CNTG
| $4.41M | 0.1% | 409,388 +34,693 | +9% | +$374K |
|
|
FPRX
61
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.1M | 0.09% | 241,243 -86,171 | -26% | -$1.47M |
|
62
Merus
MRUS
$4.98B
| $4.02M | 0.09% | 229,233 +38,825 | +20% | +$681K |
|
63
Johnson & Johnson
JNJ
$427B
| $4.01M | 0.09% | 25,495 | – | – |
|
|
GOOS
64
Canada Goose Holdings
GOOS
$1.26B
| $3.49M | 0.08% | 117,149 -210,687 | -64% | -$6.27M |
|
65
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.41M | 0.08% | 458,075 -4,327 | -0.9% | -$32.2K |
|
66
Sangamo Therapeutics
SGMO
$157M
| $3.41M | 0.08% | 218,336 | – | – |
|
|
SYNH
67
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.26M | 0.07% | +47,839 | New | +$3.26M |
|
68
Alkermes
ALKS
$4.78B
| $3.25M | 0.07% | 162,716 | – | – |
|
69
Cardinal Health
CAH
$35.5B
| $3.18M | 0.07% | 59,419 +14,749 | +33% | +$790K |
|
70
PayPal
PYPL
$67.1B
| $3.07M | 0.07% | 13,099 | – | – |
|
|
BPMC
71
DELISTED
Blueprint Medicines
BPMC
| $3.04M | 0.07% | 27,121 -12,390 | -31% | -$1.39M |
|
72
Agios Pharmaceuticals
AGIO
$2.19B
| $2.98M | 0.07% | 68,752 | – | – |
|
73
Mersana Therapeutics
MRSN
$36.5M
| $2.95M | 0.07% | 110,906 | – | – |
|
|
ORTX
74
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.92M | 0.07% | 675,969 +263,992 | +64% | +$1.14M |
|
75
Dianthus Therapeutics
DNTH
$759M
| $2.82M | 0.06% | 359,133 +117,670 | +49% | +$923K |
|